MedPath

Hydrocortisone valerate

Generic Name
Hydrocortisone valerate
Brand Names
Hydroval
Drug Type
Small Molecule
Chemical Formula
C26H38O6
CAS Number
57524-89-7
Unique Ingredient Identifier
68717P8FUZ

Overview

No overview information available.

Background

No background information available.

Indication

For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Also used to treat endocrine (hormonal) disorders (adrenal insufficiency, Addisons disease). It is also used to treat many immune and allergic disorders, such as arthritis, lupus, severe psoriasis, severe asthma, ulcerative colitis, and Crohn's disease.

Associated Conditions

  • Corticosteroid-responsive dermatoses

Clinical Trials

No clinical trials found for this drug

FDA Approved Products

Hydrocortisone Valerate
Manufacturer:Physicians Total Care, Inc.
Route:TOPICAL
Strength:2 mg in 1 g
Approved: 2010/10/29
NDC:54868-5251
Hydrocortisone Valerate
Manufacturer:Physicians Total Care, Inc.
Route:TOPICAL
Strength:2 mg in 1 g
Approved: 2010/10/29
NDC:54868-4451
HYDROCORTISONE VALERATE
Manufacturer:Cosette Pharmaceuticals, Inc.
Route:TOPICAL
Strength:2 mg in 1 g
Approved: 2023/11/29
NDC:0713-0720
Hydrocortisone Valerate
Manufacturer:Taro Pharmaceuticals U.S.A., Inc.
Route:TOPICAL
Strength:2 mg in 1 g
Approved: 2023/01/25
NDC:51672-1292
Hydrocortisone Valerate
Manufacturer:Taro Pharmaceuticals U.S.A., Inc.
Route:TOPICAL
Strength:2 mg in 1 g
Approved: 2023/01/25
NDC:51672-1290

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath